データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Grant of Restricted Stock Units and Warrants to Employees in Genmab
Genmab to Participate in a Fireside Chat at the Goldman Sachs 45th Annual Global Healthcare Conference
Investigational Acasunlimab (DuoBody -PD-L1x4-1BB) in Combination With Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients With Previously Treated Metastatic Non-small Cell Lung Cancer (MNSCLC)
Genmab Completes Acquisition of ProfoundBio
6-K:海外発行者報告書(決算情報)
Capital Increase in Genmab as a Result of Employee Warrant Exercise
データなし
データなし